Skip to content

Antioxidants Vitamins and Muscle Damage

Antioxidants Vitamins and Muscle Damage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05127928
Acronym
Antioxidant
Enrollment
18
Registered
2021-11-19
Start date
2022-02-10
Completion date
2022-03-06
Last updated
2022-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxidative Stress

Keywords

antioxidant vitamins, oxidative damage

Brief summary

Determine if acute supplementation with antioxidant vitamins (vitamin C and vitamin E) influences the muscle damage and fatigue caused after an acute session of eccentric training.

Detailed description

A randomized, single-blind, placebo-control parallel trial will be conducted. In a previous session volunteers will be interviewed to determine if they meet the inclusion criteria. Participants should avoid ingesting of foods that contain high amounts of antioxidant compounds: more than two juices of fruits, more than four cups of coffee or tea. Juices with high antioxidant content should be avoided. Alcoholic beverages should also be avoided. Participants will be divided in to groups and will performance one resistance exercise sessions. Prior to exercise, one group will intake supplementation VitC (1000 mg) + VitE (235 mg) and the other supplementation with placebo. The following sequence will be performed in each session: 1) baseline assessment (analysis of the composition body, blood draw and parameters of performance) prior to exercise session ; 2) administration of vitamin or placebo supplementation 2 hours before exercise session ; 3) post-exercise assessments (blood biomarkers and performance parameters) immediately after the session and after 24 hours. DOMS will also be assessed 48 h and 72 h after training. The training session implemented will be designed by a Sport Scientific

Interventions

DIETARY_SUPPLEMENTDietary Supplement: Vitamin C and vitamin E

Antioxidant supplementation

DIETARY_SUPPLEMENTPlacebo

Placebo administration

Sponsors

Universidad Europea de Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 33 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Physically active

Exclusion criteria

* Injuries * Supplementation or drugs * Smokers

Design outcomes

Primary

MeasureTime frameDescription
Percentage of body fat and muscle massPrior to the interventionDetermination of body composition using skinfolds measurements
DOMS0 hours post exerciseDelayed onset muscle soreness. This outcome will be measure with a 10-point visual analogic scale (0= no pain; 10 = worst possible pain)
Blood malondialdehyde (MDA)2 hours prior to exerciseMDA will be analyzed from a blood sample
Blood creatine quinase (CK)2 hours prior to exerciseCK will be analyzed from a blood sample
Jump height in a Counter Movement Jump2 hours prior to exerciseJump height (cm) in a counter movement jump measured with Octojump Platform
Jump Height in a Squat Jump24 h after exerciseJump Height (cm) in a Squat Jump measured with Octojump Platform
Jump Height in a squat Jump2 hours prior to exerciseJump height (cm) in a squat jump with Octojump Platform measured with Octojump Platform
Jump Height in a Drop Jump2 hours prior to exerciseJump height (cm) was measured in different drop jumps with Octojump Platform
Contact time in a Drop JumpInmediately after exerciseContact time (s)measured in different drop jumps with Octojump Platform
Concentration of blood lactate2 hours before exerciseCapillary blood lactate with Lactate Pro 2

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026